Meirong R. Zang

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Secondary poor graft function after autologous stem cell transplantation in multiple myeloma: a case-based expert review and successful rescue with secondary autologous stem cell infusion.

Secondary poor graft function after autologous stem cell transplantation in multiple myeloma: a case-based expert review and successful rescue with secondary autologous stem cell infusion.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 23, 2026

Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma.

Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma.

Journal: Annals of hematology

Published: September 26, 2023

Etiology of Nasal Bone Fracture: A Retrospective Analysis of 1,441 Patients in China.

Etiology of Nasal Bone Fracture: A Retrospective Analysis of 1,441 Patients in China.

Journal: The Journal of craniofacial surgery

Published: August 30, 2022

Vitamin C alleviates LPS-induced myocardial injury by inhibiting pyroptosis via the ROS-AKT/mTOR signalling pathway.

Vitamin C alleviates LPS-induced myocardial injury by inhibiting pyroptosis via the ROS-AKT/mTOR signalling pathway.

Journal: BMC cardiovascular disorders

Published: May 11, 2022

Cdc37 Contributes to bortezomib resistance in multiple myeloma via autophagy

Cdc37 Contributes to bortezomib resistance in multiple myeloma via autophagy

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: August 19, 2020

Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s.

Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s.

Journal: Oncogenesis

Published: November 02, 2019

Cheek blood sampling of mice

Cheek blood sampling of mice

Journal: Zhonghua yi xue za zhi

Published: March 03, 2016

Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.

Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.

Journal: Oncotarget

Published: September 08, 2015

Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.

Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.

Journal: Oncotarget

Published: June 27, 2015

The impact of renal function on prognostic value of β₂-microglobulin of ISS stage system in multiple myeloma patients--Clinical data analysis of 666 patients in a single center

The impact of renal function on prognostic value of β₂-microglobulin of ISS stage system in multiple myeloma patients--Clinical data analysis of 666 patients in a single center

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: June 03, 2015

Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma.

Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma.

Journal: Leukemia research

Published: March 22, 2015

Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.

Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.

Journal: Oncotarget

Published: January 09, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026